FY16
Assets2,308.34
Net Worth851.81
Total Debt928.83
RevenueAnnualised basis1,780.83
EBITDAAnnualised basis389.60
PATAnnualised basis143.56
EBITDA Margin (%)21.88
At a glance
Updated 2026-09-29Laurus Labs is an IPO with an issue size of ₹1,331.80 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹1,331.80 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗PENDINGBidding has not started yet.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets2,580.53₹ Cr · +102.7% vs prior year
Net Worth928.93₹ Cr · +22.5% vs prior year
FY15
Assets1,892.54
Net Worth722.10
Total Debt735.30
RevenueAnnualised basis1,326.31
EBITDAAnnualised basis239.40
PATAnnualised basis73.51
EBITDA Margin (%)18.05
FY14
Assets1,273.05
Net Worth758.41
Total Debt500.35
RevenueAnnualised basis1,159.71
EBITDAAnnualised basis217.68
PATAnnualised basis97.21
EBITDA Margin (%)18.77
30-Sep-16
Assets2,580.53
Net Worth928.93
Total Debt845.42
RevenueAnnualised basis927.54
EBITDAAnnualised basis213.63
PATAnnualised basis82.01
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Laurus Labs IPO | — | 30.00 x | — | — |
| Symbiotec Pharmalab IPO | — | 61.88 x | — | — |
| Sai Parenteral's IPO | — | 111.58 x | — | — |
| Corona Remedies IPO | — | 35.15 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-29.
IPO UPDATE ALERTS
Register for IPO Updates →Track Laurus Labs without missing an update
Register for subscription, GMP, allotment and listing notifications.